Biocon reaches settlement agreement with Amgen regarding biosimilars for Prolia and Xgeva, according to Drug Store News.
Biocon, a biopharmaceutical company, has agreed to a settlement with Amgen, a multinational biotechnology company, regarding the biosimilars of Prolia and Xgeva. Prolia and Xgeva are two popular medications developed by Amgen, used to treat osteoporosis and prevent...
The White House’s strategy on drugs is marked by several notable oversights.
The White House has unveiled a comprehensive plan to tackle the nation's drug crisis, but critics argue that it has some notable blind spots. The plan, which focuses on combating the opioid epidemic, improving treatment access, and reducing drug trafficking, has been...
Zydus receives approval from the US Food and Drug Administration for a novel medication, as reported by Ahmedabad Mirror.
Zydus, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for a new drug. This approval is a significant milestone for the company, as it demonstrates its ability to develop and manufacture high-quality...
Delhi High Court Provides Temporary Protection for ‘Kind’ Trademark Family in Ongoing Legal Dispute
The Delhi High Court has granted an ex-parte ad-interim injunction in favor of Mankind Pharma Limited, a leading pharmaceutical company in India, to protect its well-established "Kind" family of marks. The court's decision was made in response to the defendant's use...
Late UN Mehta’s humble beginnings scaled to a $21 billion empire: VGRC honors Torrent Group founder’s legacy
The VGRC (Vrijlal G. Rajani Centre) recently celebrated the legacy of late UN Mehta, the founder of the Torrent Group. Mehta's journey is an inspiring rags-to-riches story, as he transformed a small company into a $21 billion empire. Starting with a humble beginning,...
Lupin’s Pithampur Unit 2 facility receives USFDA’s Official Action Indicated (OAI) status.
Lupin, a pharmaceutical company, has recently received the USFDA OAI (Official Action Indicated) status for its Pithampur Unit 2 facility. The USFDA (United States Food and Drug Administration) is responsible for ensuring the safety and efficacy of drugs and medical...
Torrent Pharmaceuticals receives demand notices worth Rs 6.63 crore from National Pharmaceutical Pricing Authority
Torrent Pharmaceuticals, a prominent drug manufacturer, has received demand notices from the National Pharmaceutical Pricing Authority (NPPA) totaling over Rs 6.63 crore. The notices, issued under Para 15 of the Drug Price Control Order 2013 (DPCO), impose a penalty...
Sharvil Patel, Managing Director of Zydus Lifesciences, has been appointed as the new president of the Indian Pharmaceutical Alliance.
The Indian Pharmaceutical Alliance (IPA) has announced a new leadership team, with Sharvil Patel, Managing Director of Zydus Lifesciences, taking over as President. Patel succeeds Samir Mehta, Chairman of the Torrent Group, and will be joined by Glenn Saldanha,...
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association
Zydus Lifesciences' Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
Five pharmaceutical companies, including Sun Pharma and Zydus, have issued recalls for their products in the US market.
Sun Pharma, Zydus, and three other pharmaceutical companies have issued recalls for their products in the US market. The recalls were initiated due to various reasons, including contamination, labeling issues, and deviations from manufacturing standards. Sun Pharma,...
Several Indian pharmaceutical companies, including Glenmark, Granules, and Zydus, have issued recalls for certain medications in the US market due to concerns over quality, as reported by the US Food and Drug Administration (USFDA).
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, as reported by the US Food and Drug Administration (USFDA). The recalls are related to manufacturing problems, impurities, and labeling errors. Glenmark...
Several pharmaceutical companies, including Zydus, Sun Pharma, and Glenmark, have issued recalls of their medications in the US due to concerns regarding quality standards.
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, including manufacturing problems, impurities, and labeling errors, as reported by the US Food and Drug Administration (USFDA). The recalls affect a range of...
Generic pharmaceutical companies dodge significant damage, avoiding a medical emergency.
India's generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump's 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies. However, some...
From Humble Beginnings to International Dominion
Dilip Shanghvi, the founder of Sun Pharmaceutical Industries (Sun Pharma), is one of India's most prominent self-made billionaires. Born in 1955 in Amreli, Gujarat, Shanghvi grew up in Kolkata, where his father ran a small pharmacy shop. From a young age, Shanghvi...
Regulatory authorities have instructed Sun Pharma to restrict its Phase III Revefenacin study to only include patients with COPD who are currently on triple therapy.
Sun Pharmaceutical Industries Ltd, a prominent pharmaceutical company, has been instructed to limit the phase III study of Revefenacin to patients with Chronic Obstructive Pulmonary Disease (COPD) who are already receiving triple therapy. This decision comes as a...
Natco Pharma considers splitting off its agricultural division.
Natco Pharma, a generic drugmaker, is considering spinning off its agro business into a separate entity. The company's board of directors has given in-principle approval for the demerger, which is expected to unlock value in the core pharmaceuticals business and Drive...
Rajiv Nannapaneni, the CEO of Natco Pharma
Rajiv Nannapaneni, CEO of Natco Pharma, believes that the Indian pharma sector is not threatened by the recent US trade tariffs. He attributes this to the fact that the US consumes 92% of Indian generic drugs, making it reliant on Indian pharmaceuticals. Nannapaneni...
Indian generic companies intensify challenge to Novo Nordisk’s weight-loss medication patent
A patent battle is unfolding in India between Danish pharmaceutical company Novo Nordisk and Indian pharmaceutical companies, particularly Hyderabad-based Natco Pharma. The dispute centers around Novo Nordisk's blockbuster weight-loss drug, semaglutide, which is sold...
Natco Pharma files lawsuit against Novo Nordisk in Delhi courts regarding intellectual property dispute over Semaglutide.
Natco Pharma, an Indian pharmaceutical company, has filed a lawsuit against Novo Nordisk, a Danish multinational pharmaceutical company, in a Delhi court over intellectual property rights related to semaglutide. Semaglutide is a medication used to treat type 2...
Natco Pharma names TC Mallikarjun as its new Vice President.
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President - Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen its...
Access to the Request Has Been Denied
It appears that you have encountered an error while trying to access the website www.tipranks.com. The error message indicates that your request was blocked by Link11 Web Application Security, which is a security system designed to protect websites from malicious...
US FDA issues single Form 483 observation to NATCO Pharma’s Hyderabad plant following audit.
NATCO Pharma, a leading pharmaceutical company based in Hyderabad, India, has received a positive outcome from a recent US Food and Drug Administration (US FDA) audit. The company's plant, located in Hyderabad, was inspected by the US FDA, and the audit resulted in...
Natco Pharma’s Q4 net profit sees 5% year-over-year increase, reaching ₹406 crore.
Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company's quarterly...
Biocon reaches settlement agreement with Amgen regarding biosimilars for Prolia and Xgeva, according to Drug Store News.
Biocon, a biopharmaceutical company, has agreed to a settlement with Amgen, a multinational biotechnology company, regarding the biosimilars of Prolia and Xgeva. Prolia and Xgeva are two popular medications developed by Amgen, used to treat osteoporosis and prevent...
The White House’s strategy on drugs is marked by several notable oversights.
The White House has unveiled a comprehensive plan to tackle the nation's drug crisis, but critics argue that it has some notable blind spots. The plan, which focuses on combating the opioid epidemic, improving treatment access, and reducing drug trafficking, has been...
Zydus receives approval from the US Food and Drug Administration for a novel medication, as reported by Ahmedabad Mirror.
Zydus, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for a new drug. This approval is a significant milestone for the company, as it demonstrates its ability to develop and manufacture high-quality...
Delhi High Court Provides Temporary Protection for ‘Kind’ Trademark Family in Ongoing Legal Dispute
The Delhi High Court has granted an ex-parte ad-interim injunction in favor of Mankind Pharma Limited, a leading pharmaceutical company in India, to protect its well-established "Kind" family of marks. The court's decision was made in response to the defendant's use...
Late UN Mehta’s humble beginnings scaled to a $21 billion empire: VGRC honors Torrent Group founder’s legacy
The VGRC (Vrijlal G. Rajani Centre) recently celebrated the legacy of late UN Mehta, the founder of the Torrent Group. Mehta's journey is an inspiring rags-to-riches story, as he transformed a small company into a $21 billion empire. Starting with a humble beginning,...
Lupin’s Pithampur Unit 2 facility receives USFDA’s Official Action Indicated (OAI) status.
Lupin, a pharmaceutical company, has recently received the USFDA OAI (Official Action Indicated) status for its Pithampur Unit 2 facility. The USFDA (United States Food and Drug Administration) is responsible for ensuring the safety and efficacy of drugs and medical...
Torrent Pharmaceuticals receives demand notices worth Rs 6.63 crore from National Pharmaceutical Pricing Authority
Torrent Pharmaceuticals, a prominent drug manufacturer, has received demand notices from the National Pharmaceutical Pricing Authority (NPPA) totaling over Rs 6.63 crore. The notices, issued under Para 15 of the Drug Price Control Order 2013 (DPCO), impose a penalty...
Sharvil Patel, Managing Director of Zydus Lifesciences, has been appointed as the new president of the Indian Pharmaceutical Alliance.
The Indian Pharmaceutical Alliance (IPA) has announced a new leadership team, with Sharvil Patel, Managing Director of Zydus Lifesciences, taking over as President. Patel succeeds Samir Mehta, Chairman of the Torrent Group, and will be joined by Glenn Saldanha,...
How He Transformed Cipla into a Worldwide Pharmaceutical Powerhouse
Yusuf Hamied, the Chairman of Cipla, is a leader who has transformed the global pharmaceutical landscape by advocating for affordable medications and lifesaving therapies. Born on July 25, 1936, in Vilnius, Lithuania, Hamied moved to India with his family and later...
Shivam Puri, Managing Director and CEO of Cipla Health Ltd, to serve on the Grand Jury for IMA 2025, as reported by Exchange4Media.
The Indian Media Awards (IMA) 2025 Grand Jury consists of esteemed industry professionals, including Shivam Puri, Managing Director & CEO of Cipla Health Ltd. As reported by Exchange4Media, the IMA 2025 aims to recognize and celebrate excellence in the media industry....
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association
Zydus Lifesciences' Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
Generic pharmaceutical companies dodge significant damage, avoiding a medical emergency.
India's generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump's 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies. However, some...
Cipla Group company InvaGen Pharmaceuticals partners with Bora Biologics for production of NYPOZI at their San Diego facility.
Bora Biologics has partnered with InvaGen Pharmaceuticals, a subsidiary of Cipla Group, to manufacture NYPOZI(TM) at its San Diego facility. This partnership marks a significant milestone in the production of NYPOZI(TM), a crucial medication for patients in need. Bora...
Umang Vohra set to step down, with Achin Gupta poised to succeed as new Global CEO.
In a significant development, Cipla, a leading pharmaceutical company, is undergoing a leadership shift. Umang Vohra, the current Managing Director and Global Chief Executive Officer (CEO), has decided to exit the company. Vohra's departure marks the end of an era at...
Umang Vohra, Managing Director of Cipla, is reportedly set to resign, with Chief Operating Officer Achin Gupta likely to take over his position.
Indian pharmaceutical company Cipla is reportedly preparing for a significant management change. Umang Vohra, the company's managing director and global CEO, is expected to step down by the end of the current fiscal year. Vohra, 54, has been in the role for nearly a...
Mahindra University collaborates with Apollo Healthcare Academy to introduce Bachelor’s Programs in Allied Health Sciences through a Memorandum of Understanding, as reported by Chennai Patrika, a source for Tamil Cinema News, Kollywood News, and India News.
Mahindra University, Hyderabad, and Apollo Healthcare Academy have signed a Memorandum of Understanding (MoU) to offer Bachelor's programs in Allied Health Sciences. The partnership aims to address the growing shortage of allied health professionals in India and...
Mahindra University partners with Apollo Healthcare Academy to launch collaborative programme through Memorandum of Understanding
Mahindra University, located in Hyderabad, has partnered with Apollo Healthcare Academy to offer Bachelor's programs in Allied Health Sciences. The collaboration aims to produce practice-ready graduates who meet the demands of the healthcare industry. The programs...
Artificial intelligence, genomics, and the future trajectory of cardiac innovation are poised to revolutionize India’s healthcare economy.
Cardiovascular disease is a significant health challenge in India, affecting people at a younger age and resulting in increased morbidity, premature deaths, and high healthcare expenditures. To address this, technology such as Artificial Intelligence (AI) and genomics...
Apollo Hospitals inks deal with Iraq to operate Internal Security Force Hospital, reports ETHealthworld
Apollo Hospitals has signed an agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. This partnership aims to provide advanced medical care to Iraq's security forces and their families, further...
Apollo Hospitals inks deal to run Iraq’s Internal Security Force Hospital
Apollo Hospitals has signed a strategic agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. This partnership aims to provide advanced medical care to Iraq's security forces and their families, further...
Apollo Hospitals has partnered with Iraq to take over operational management of the Internal Security Force Hospital.
Apollo Hospitals has signed a strategic agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. This collaboration aims to provide advanced medical care to Iraq's security forces and their families,...
Kolkata’s Apollo Hospital Reaches Milestone in Cancer Treatment with Breakthrough CAR-T Cell Therapy
In a significant breakthrough for cancer treatment in Eastern India, Apollo Multispeciality Hospitals in Kolkata has successfully administered CAR-T cell therapy to a 31-year-old engineer with high-risk Pre-B Acute Lymphoblastic Leukemia (ALL). This marks the...
Apollo Hospitals Hyderguda and Cardiac Rehab Foundation organize a run to promote awareness about heart health.
On a recent day, the Apollo Hospitals Hyderguda and the Cardiac Rehab Foundation joined forces to host a run with the aim of raising awareness about heart health. This event was part of a broader initiative to educate the public about the importance of maintaining a...
Pfizer partner Metsera highlights promising Phase II results for its GLP-1 candidate.
Metsera Therapeutics, a biotech company set to be acquired by Pfizer, has announced positive results from two Phase II trials for its GLP-1 receptor agonist, MSE-1018. The trials evaluated the efficacy and safety of MSE-1018 in patients with type 2 diabetes and...
Former Johnson & Johnson and Pfizer executive takes the reins as new CEO of Revision Skincare.
Lisa Paley, a seasoned consumer health executive, has been appointed as the CEO of Revision Skincare, a professional-grade skincare company based in Irving. Paley brings nearly 30 years of experience leading major global brands, including Haleon, GSK, Pfizer, and...
Pfizer’s acquisition of Metsera sparks significant changes in the obesity treatment landscape.
The pharmaceutical industry is witnessing a significant shift in the obesity treatment landscape, with Pfizer's recent acquisition of Metsera, a biotech company developing an obesity therapy, being a key catalyst. This deal has major implications for the obesity race,...
Ireland’s ‘Viagra Village’ faces uncertainty amid Trump’s tariffs – Politico.eu
In the small village of Ringaskiddy, Ireland, a significant pharmaceutical plant owned by Pfizer manufactures Viagra, among other medications. The village has come to be known as "Viagra Village" due to its association with the popular erectile dysfunction medication....
Pfizer is nearing a $7.3 billion acquisition of Metsera, a company that produces anti-obesity medications, according to a report from the Financial Times.
Pfizer, a multinational pharmaceutical corporation, is reportedly nearing a $7.3 billion takeover of Metsera, a company that specializes in developing anti-obesity treatments. According to the Financial Times, the acquisition is expected to be finalized soon, pending...
Pfizer and Roivant’s novel therapy demonstrates significant patient-centered advantages in treating a rare inflammatory disorder, according to recent findings reported by BioSpace.
A recent study has shown that a therapy developed by Roivant Sciences and Pfizer has demonstrated a "patient-centered benefit" in treating a rare inflammatory condition. The condition, known as sjögren-Larsson syndrome, is a genetic disorder that affects the skin,...
Teamwork Financial Advisors LLC increases its stake in Pfizer Inc., ticker symbol $PFE, according to MarketBeat.
Teamwork Financial Advisors LLC has increased its stake in Pfizer Inc. ($PFE), a multinational pharmaceutical corporation. According to recent filings, Teamwork Financial Advisors LLC has raised its holdings in Pfizer, indicating a growing confidence in the company's...
Pfizer Vietnam, in partnership with Long Chau, aims to provide training for pharmacy and vaccination professionals.
Pfizer Vietnam and Long Chau Pharmacy & Vaccination Centres have signed a Memorandum of Understanding (MoU) to collaborate on enhancing the capabilities of thousands of healthcare professionals in Vietnam. The two-year partnership aims to improve healthcare quality by...
Statement released by Fortis Mohali regarding the health status of Punjabi singer Rajvir Jawanda.
Fortis Hospital in Mohali has issued a statement regarding the condition of Punjabi singer Rajvir Jawanda, who was admitted to the hospital after being shot in the United States. According to the statement, Jawanda is currently undergoing treatment at the hospital and...
Fortis in India plans to increase the number of its obesity clinics due to a surge in demand for weight-loss treatments, according to the company’s CEO.
India's Fortis Healthcare is planning to expand its obesity clinics across the country, according to its CEO. The move comes as the demand for weight-loss therapies is on the rise. The company aims to capitalize on the growing trend of people seeking medical help to...
Fortis introduces specialized orthopaedic and sports injury outpatient department in Srinagar
Fortis Healthcare has launched a monthly Orthopaedics and Sports Injury Outpatient Department (OPD) in Srinagar, aimed at providing specialized musculoskeletal and sports medicine care to residents. The OPD will be led by Dr. Tapish Shukla, an Associate Consultant in...
Hospitals are experiencing a significant change in their revenue streams, with oncology emerging as the most lucrative department.
India's top hospital chains, including Max Healthcare, Apollo Hospitals, and Fortis Healthcare, are experiencing a significant shift in their revenue mix, with oncology emerging as the fastest-growing and most profitable specialty. Oncology, once a niche segment, is...
Punjab’s Chief Minister is exhibiting signs of improvement while being closely monitored at Fortis Hospital.
Punjab Chief Minister Bhagwant Mann was admitted to Fortis Hospital in Mohali on Friday evening due to exhaustion and a low heart rate. The 51-year-old leader has been showing improvement, with stable vital signs and gradually improving blood parameters, according to...
Punjab Chief Minister Bhagwant Mann’s condition worsens, hospitalized at Fortis Mohali
Punjab Chief Minister Bhagwant Mann has been admitted to Fortis Hospital in Mohali due to health concerns. According to reports, Mann complained of exhaustion and a low heart rate, prompting his hospitalization. The news has led to the postponement of a scheduled...
Fortis Hospital in Mohali hosts the zonal finals of ‘PSYCH-ED 2025’
Fortis Hospital, Mohali, recently hosted the zonal finals of the 8th edition of its national psychology quiz program, "PSYCH-ED, 2025". The event saw participation from over 900 schools across India, with more than 12,000 students from 190+ cities taking part in the...
Fortis acquires Shrimann hospital in a massive Rs 462 crore deal
Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The...